Inhibition of adenylyl cyclase activity by the cholecystokinin analog SNF 9007 in neuroblastoma × glioma NG108-15 hybrid cells

Regulatory Peptides

Volumn 61, Issue 1, 1996, Pages 51-56

  Roerig, Sandra C ^a   Williams, Cynthia L ^b   Hruby, Victor J ^c   Burks, Thomas F ^b   Rosenfeld, Gary C ^b  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c University of Arizona ^*  (United States)

Author keywords

Cyclic adenosine monophosphate (cAMP); Delta opioid receptor; Opioid; Second messenger

Indexed keywords

7 BENZYLIDENENALTREXONE; ADENYLATE CYCLASE; CHOLECYSTOKININ DERIVATIVE; CHOLECYSTOKININ OCTAPEPTIDE; CYCLIC AMP; DELTA OPIATE RECEPTOR; DELTORPHIN; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; FORSKOLIN; NALTRIBEN; OPIATE ANTAGONIST; OPIATE RECEPTOR; ROLIPRAM; SNF 9007; UNCLASSIFIED DRUG;

ARTICLE; ENZYME ACTIVITY; GLIOMA; HUMAN; HUMAN CELL; HYBRID CELL; NEUROBLASTOMA; PRIORITY JOURNAL;

ADENYLATE CYCLASE; AMINO ACID SEQUENCE; ANALGESICS; CHOLECYSTOKININ; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; ENZYME INHIBITORS; GLIOMA; HYBRID CELLS; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; OLIGOPEPTIDES; PAIN; PEPTIDE FRAGMENTS; RECEPTORS, OPIOID, DELTA;

EID: 0030050788     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-0115(95)00137-9     Document Type: Article

References (38)

1. Baber, N.S., Dourish, C.T. and Hill, D.R., The role of CCK, caerulein, and CCK antagonists in nociception, Pain, 39 (1989) 307-328.
2. Stanfa, L., Dickenson, A., Xu, X.-J. and Wiesenfeld-Hallin, Z., Cholecystokinin and morphine analgesia: variations on a theme, Trends Pharmacol. Sci., 15 (1994) 65-66.
3. Noble, F., Derrien, M. and Roques, B.P., Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain, Br. J. Pharmacol., 109 (1993) 1064-1070.
4. Suh, H.H., Collins, K.A. and Tseng, L.F., Intrathecal cholecystokinin octapeptide attenuates the antinociception and release of immunoreactive Met-enkephalin induced by intraventricular β-endorphin in the rat, Neuropeptides, 21 (1992) 131-137.
5. Faris, P.L., Komisaruk, B.R., Watkins, L.R. and Mayer, D.J., Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia, Science, 219 (1983) 310-312.
6. Itoh, S., Katsuura, G. and Maeda, Y., Caerulein and cholecystokinin suppress beta-endorphin-induced analgesia in the rat, Eur. J. Pharmacol., 80 (1982) 421-425.
7. Cesselin, F., Bourgoin, S., Artaud, F. and Hamon, M., Basic and regulatory mechanisms of in vitro release of met-enkephalin from the dorsal zone of the rat spinal cord, J. Neurochem., 43 (1984) 763-774.
8. Hong, E.K. and Takemori, A.E., Indirect involvement of delta opioid receptors in cholecystokinin octapeptide-induced analgesia in mice, J. Pharmacol. Exp. Ther., 251 (1989) 594-598.
9. Barbaz, B.S., Autry, W.L., Ambrose, F.G., Gerber, R. and Liebman, J.M., Antagonism of cholecystokinin by naloxone and proglumide in mice, Ann. New York Acad. Sci., 448 (1985) 573-574.
10. Wang, X.-J., Want, X.-H. and Han, J.-C., Cholecystokinin octapeptide antagonized opioid analgesia mediated by μ- and κ- but not δ-receptors in the spinal cord of the rat, Brain Res., 523 (1990) 5-10.
11. Slaninova, J., Knapp, R.J., Wu, J., Fang, S.-N., Kramer, T., Burks, T.F., Hruby, V.J. and Yamamura, H.I., Opioid receptor binding properties of analgesic analogues of cholecystokinin octapeptide, Eur. J. Pharmacol., 200 (1991) 195-198.
12. 2 and μ opioid receptors, J. Pharmacol. Exp. Ther., 269 (1994) 750-755.
13. Nicholson, D., Reid, A. and Sawynok, J., Effects of forskolin and phosphodiesterase inhibitors on spinal antinociception by morphine, Pharm. Biochem. Behav., 38 (1991) 753-758.
14. Praewlocka, B., Dziedzicka, M., Lason, W. and Przewlocki, R., Differential effects of opioid receptor agonists on nociception and cAMP level in the spinal cord of monoarthritic rats, Life Sci., 50 (1991) 45-54.
15. Chang, K.J., Miller, R.J. and Cuatrecasas, P., Interaction of enkaphalin with opiate receptors in intact cultured cells, Mol. Pharmacol., 14 (1978) 961-970.
16. Evans, C.J., Keith, D.E., Morrison, H., Magendzo, K. and Edwards, R.H., Cloning of a delta opioid receptor by functional expression. Science, 258 (1992) 1952-1955.
17. Kieffer, B.L., Befort, K., Gaveriauz-Ruff, C. and Hirth, C.G., The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization, Proc. Natl. Acad. Sci. USA, 89 (1992) 12048-12052.
18. Law, P.Y., Koehler, J.E. and Loh, H.H., Comparison of opiate inhibition of adenylate cyclase activity in neuroblastoma N18TG2 and neuroblastoma × glioma NG108-15 hybrid cell lines, Mol. Pharmacol., 21 (1982) 483-491.
19. Malm, D., Giaever, A., Vonen, B. and Florholmen, J., Cholecystokinin and somatostatin modulate the glucose-induced insulin secretion by different mechanisms in pancreatic islets. A study on phospholipase C activity and calcium requirement, Scand. J. Clin. Lab. Invest., 53 (1993) 671-676.
20. Lee, Y.-M., Beinborn, M., McBride, E.W., Lu, M., Lee F., Kolakowski, J. and Kopin, A.S., The human brain cholecystokinin-B/gastrin receptor cloning and characterization. J. Biol. Chem., 268 (1993) 8164-8169.
21. Zhang, L.J., Han, N.L. and Han, J.S., Regulation by lithium of the antagonistic effect of cholecystokinin octapeptide on ohmefentanyl-induced antinociception, Neuropharmacology, 33 (1994) 123-126.
22. Rao, R.K., S. Levenson, Fang, S.N., Hruby, F.J., Yamamura, H.I. and Porreca, F., Characterization of SN9007, a novel cholecystokinin/opioid ligand in mouse ileum in vitro: evidence for involvement of cholecystokininA and cholecystokininB receptors in regulation of ion transport, J. Pharmacol. Exp. Ther., 268 (1994) 1003-1009.
23. White, A.A. and Karr, D.B., Improved two-step method for the assay of adenylate and guanylate cyclase, Anal. Biochem., 85 (1978) 451-460.
24. Lowry, O.H., Rosbrough, N.J., Farr, A.L. and Randall, R.J., Protein measurement with the folin phenol reagent, J. Biol. Chem., 193 (1951) 265-275.
25. Mosberg, H.I., Hurst, R., Hruby, V.J., Gee, K., Yammaura, H.I., Galligan, J.J. and Burks, T.F., Bis-penicillamine enkephalins possess highly improved specificity toward δ opioid receptors, Proc. Natl. Acad. Sci. USA, 80 (1983) 5871-5874.
26. Mattia, A., Farmer, S.C., Takemori, A.E., Sultana, M., Portoghese, P.S., Mosberg, H.I., Bowen, W.D. and Porreca, F., Spinal opioid delta antinociception in the mouse: mediation by a 5-NTII-sensitive delta receptor subtype, J. Pharmacol. Exp. Ther., 260 (1992) 518-525.
27. Sofuglu, M., Portoghese, P.S. and Takemori, A.E., Differential antagonism of delta opioid agonists by naltrindole (NTI) and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes, J. Pharmacol. Exp. Ther., 257 (1991) 676-680.
28. Takemori, A.E. and Portoghese, P.S., Selective naltrexone-derived opioid receptor antagonists, Annu. Rev. Pharmacol. Toxicol., 32 (1992) 239-269.
29. 1-opioid receptor antagonist: 7-benzylidenenaltrexone, Eur. J. Pharmacol., 218 (1992) 195-196.
30. Tallarida, R.J. and Murray, R.B., Manual of Pharmacologic Calculations, Springer, New York, 1989.
31. Kong, H., Raynor, K., Yasuda, K., Moe, S.T., Portoghese, P.S., Bell, G.I. and Reisine, T., A single residue, aspartic acid 95, in the δ opioid receptor specifies selective high affinity agonist binding, J. Biol. Chem., 268 (1994) 23055-23058.
32. Derrien, M., Noble, F., Maldonado, R. and Roques, B.P., Cholecystokinin-A but not cholecystokinin-B receptor stimulation induces endogenous opioid-dependent antinociceptive effects in the hot plate test in mice, Neurosci. Lett., 160 (1993) 193-196.
33. Noble, F., Smadja, C. and Roques, B.P., Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists, J. Pharmacol. Exp. Ther., 271 (1994) 1127-1134.
34. Marino, C.R., Leach, S.D., Schaefer, J.F., Miller, L.J. and Gorelick, F.S., Characterization of cAMP-dependent protein kinase activation by CCK in rat pancreas, FEBS Lett., 316 (1993) 48-52.
35. Yule, D.I., Tseng, M.-J., Williams, J.A. and Logsdon, C.D., A cloned CCK-A receptor transduces multiple signals in response to full and partial agonists, Am. J. Physiol., 265 (1993) G999-G1004.
36. Dourish, C.T., O'Neill, M.F., Coughlan, J., Kitchener, S.J., Sawley, D. and Iversen, S.D., The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat, Eur. J. Pharmacol., 176 (1990) 35-44.
37. Zhou, Y., Sun, Y.-H., Zhang, Z.-W. and Han, J.-S., Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of μ-opioid analgesia by CCKβ receptor antagonist L-365,260 in rat spinal cord, Eur. J. Pharmacol., 234 (1993) 147-154.
38. 5]enkephalin antiserum-sensitive enhancement of morphine antinociception, NeuroReport, 5 (1994) 2601-2605.